These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8438487)

  • 1. Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction.
    Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):8-12. PubMed ID: 8438487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mixed chimerism and immune tolerance induction by low-stress pretreatment before kidney transplantation in monkeys].
    Kawai T; Hoshino T; Fujioka S; Shimuzu K; Tanabe K; Okawa T; Ota K; Cosimi A B; Sachs D H
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):670-4. PubMed ID: 8963780
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation tolerance and mixed chimerism: at the frontier of clinical application.
    Donckier V; Toungouz M; Goldman M
    Transpl Int; 2001; 14(1):1-5. PubMed ID: 11263549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to transplantation tolerance.
    Smith CV; Rosengard BR; Guzzetta PC; Nakajima K; Sachs DH
    Transplant Proc; 1991 Aug; 23(4):2157-61. PubMed ID: 1871834
    [No Abstract]   [Full Text] [Related]  

  • 5. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
    Trivedi HL; Mishra VV; Vanikar AV; Modi PR; Shah VR; Shah PR; Firoz A
    Transplant Proc; 2006 Nov; 38(9):3103-8. PubMed ID: 17112910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeking the perfect match. HLA and transplantation.
    Tait BD
    Med J Aust; 1993 Nov; 159(10):696-700. PubMed ID: 8232014
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
    Gajewski JL; Ippoliti C; Ma Y; Champlin R
    Am J Hematol; 2002 Dec; 71(4):311-3. PubMed ID: 12447962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current progress in chimerism and donor-specific tolerance.
    Jankowski RA; Ildstad ST
    Transplant Proc; 1996 Aug; 28(4):2071-4. PubMed ID: 8769159
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects and strategies for clinical tolerance.
    Monaco AP
    Transplant Proc; 2004; 36(1):227-31. PubMed ID: 15013353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed chimerism as an approach for the induction of transplantation tolerance.
    Wekerle T; Sykes M
    Transplantation; 1999 Aug; 68(4):459-67. PubMed ID: 10480398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Matching for ABO blood groups and HLA tissue types in transplantation with special reference to bone marrow transplantation].
    Jakobsen BK; Dickmeiss E; Jacobsen N; Svejgaard A
    Ugeskr Laeger; 2003 Dec; 165(50):4837-9. PubMed ID: 14716899
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
    Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue typing--minimum requirements for clinical transplantation.
    Chapman JR
    Transplant Proc; 1992 Oct; 24(5):1674-5. PubMed ID: 1412792
    [No Abstract]   [Full Text] [Related]  

  • 17. MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome.
    Kitcharoen K; Witt CS; Romphruk AV; Christiansen FT; Leelayuwat C
    Hum Immunol; 2006 Mar; 67(3):238-46. PubMed ID: 16698448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-D typing and some applications.
    Thomsen M
    Dan Med Bull; 1984 Jun; 31(3):165-86. PubMed ID: 6378536
    [No Abstract]   [Full Text] [Related]  

  • 20. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.